Forbes January 15, 2021
Biotechnology companies are battling Covid-19 and numerous other diseases such as Alzheimer’s. In this particularly timely segment of What’s Ahead, we discuss these and other subjects with Dr. Michelle McMurry-Heath, who was recently appointed president and CEO of the Biotechnology Innovation Organization, the world’s largest science and public advocacy association.
In early 2020 BIO debuted the Coronavirus Collaboration Initiative, helping to break down traditional barriers, which led to pharmaceutical companies, universities, regulatory agencies and independent laboratories creating vaccines and treatments for Covid-19 in record time.
Dr. McMurry-Heath’s extraordinary career made her the right person at the right time to lead this critical group. She was the first African-American to graduate from the Duke Medical Scientist Training Program, where...
Today's Sponsors
Today's Sponsor